Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. American Psychiatric Association A, Association AP (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association, Washington, DC
2. Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O’donnell K, Owens IT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L (2022) Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 79:953–962
3. Burke MJ, Blumberger DM (2021) Caution at psychiatry’s psychedelic frontier. Nat Med 27:1687–1688
4. Butler M, Jelen L, Rucker J (2022) Expectancy in placebo-controlled trials of psychedelics: if so, so what? Psychopharmacology 239:3047–3055
5. Carhart-harriS R, Giribaldi B, Watts R, Baker-jones M, Murphy-beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ (2021) Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med 384:1402–1411
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献